Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$6.5M Sell
188,534
-19,126
-9% -$642K 0.34% 77
2019
Q2
$7.1M Sell
207,660
-8,371
-4% -$295K 0.38% 61
2019
Q1
$7.72M Buy
216,031
+69,002
+47% +$2.35M 0.39% 63
2018
Q4
$4.73M Buy
147,029
+49,833
+51% +$1.59M 0.27% 101
2018
Q3
$3.03M Buy
97,196
+2,290
+2% +$70.5K 0.13% 235
2018
Q2
$2.88M Buy
94,906
+131
+0.1% +$3.75K 0.07% 246
2018
Q1
$2.64M Sell
94,775
-272,337
-74% -$7.35M 0.07% 251
2017
Q4
$10.3M Sell
367,112
-1,080
-0.3% -$31K 0.22% 138
2017
Q3
$9.89M Sell
368,192
-28,240
-7% -$755K 0.22% 132
2017
Q2
$10.2M Buy
396,432
+29
+0% +$738 0.24% 132
2017
Q1
$10.2M Sell
396,403
-46,178
-10% -$1.18M 0.24% 133
2016
Q4
$11.2M Sell
442,581
-16,459
-4% -$390K 0.27% 117
2016
Q3
$10.9M Sell
459,040
-11,188
-2% -$281K 0.27% 114
2016
Q2
$12.2M Buy
+470,228
New +$11.6M 0.3% 107

Other funds holding EXC

Boston Advisors's EXC Position: Q3 2019 in Review

Boston Advisors reduced its Exelon (EXC) stake by 9.2% in Q3 2019, selling an estimated $642K and leaving 188,534 shares worth $6.5M. The position accounts for 0.34% of the portfolio, ranked #77.

Boston Advisors first reported a position in EXC in Q2 2016 and has held it in 14 quarters since. The position peaked at $12.2M in Q2 2016. 963 funds tracked by Wall St. Rank hold EXC as of Q3 2019.

  • Boston Advisors held 188,534 shares of Exelon worth $6.5M as of Q3 2019.
  • Boston Advisors sold 19,126 Exelon shares in Q3 2019, an estimated $642K.
  • Exelon made up 0.34% of Boston Advisors's portfolio in Q3 2019, its #77 holding.
  • Boston Advisors first reported a position in Exelon in Q2 2016 and has held it in 14 quarters since.
  • Boston Advisors's Exelon position peaked at $12.2M in Q2 2016.
  • 963 funds tracked by Wall St. Rank held Exelon as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.